Massachusetts Institute of Technology (MIT) researchers have developed a series of soluble, stabilized cytokine receptors that could feasibly be injected into COVID-19 patients to help reduce the effects of cytokine storm by binding to excess cytokines.
#COVID19 #Coronavirus #Therapeutics
Independent research teams describe soluble cytokine receptors that might tackle cytokine storm, and suggest that a little known function of neutrophils may be involved in severe COVID-19 disease.
Comments are closed.